Fundz Deep Dive
Everything you need to win Sartorius — in one platform.
Who to reach, what to say, and why now on Sartorius — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Sartorius — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Sartorius partners with Sensible Biotechnologies to enhance mRNA production capabilities globally.
Jul 09, 2025•11 months ago
Contract Type
partnership
Description
Sartorius Stedim Biotech and Sensible Biotechnologies have signed a Memorandum of Understanding to scale up Sensible's cell-based mRNA design platform. The partnership aims to enable clinical-grade production of mRNA by 2026 and expand production facilities from Slovakia to the US, UK, and Europe.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months